• 50 women, similar baseline characteristics
• 25 (50%) randomized to CP and 25 (50%) to DICD
• High success in each cohort
• 80% (8/10) CP vs. 75% (9/12) DICD; p = 1.0
• Still using the device at 6 months
• 63% CP vs 44% DCID; p=0.64
• No serious adverse events occurred